A standoff over Elevidys could have major consequences for Duchenne patients, gene therapy companies and the perception of ...

As mothers of children with this disease, we have wept helplessly in recent months as friends — fellow members of a club we ...

Kostas Biliouris, BMO Capital Markets biotech analyst, joins CNBC's 'Squawk on the Street' to discuss the latest details on ...

A Cambridge-based company developing gene therapies for rare diseases is laying off more than a third of its workforce.

Sarepta Therapeutics refused a FDA request to halt shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy ...

The U.N. food agency says Israeli forces fired on Palestinians seeking food aid in northern Gaza on Sunday. Gaza's Health ...

PDFgear Scan, Finally, a Truly Free AI Scanner App for All. \| PDFgear today launched PDFgear Scan, the world's first free AI ...

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

Culver’s, which operates 1,000 locations across 26 states, is opening nearly two dozen new locations before the end of the year. Unsurprisingly, Wisconsin, where Culver’s was founded, has the greatest ...

Mel Cozzi and George Howe, Board of Commissioners for the City of Oregon, join WGN Radio’s Dave Plier to highlight the City of Oregon and all that it has to offer for visitors. Mel and ...

Drugmaker Sarepta Therapeutics said late Friday it won't comply with a request from the Food and Drug Administration to halt ...

Sarepta Therapeutics announced it is laying off nearly 500 employees this week, including 80 at its Easton location.